How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?

Published:2024-02-20 Issue:7 Volume:119 Page:1287-1288
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Abreu Maria T.¹²³,Kosinski Lawrence R.⁴

Affiliation:

1. Crohn's & Colitis Center, University of Miami Miller School of Medicine, Miami, Florida, USA;

2. Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA;

3. Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA;

4. SonarMD, Chicago, Illinois, USA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference11 articles.

1. Risankizumab as induction therapy for Crohn's disease: Results from the phase 3 ADVANCE and MOTIVATE induction trials;D'Haens;Lancet,2022

2. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from three phase 3, multicentre, double-blind, randomised trials;Danese;Lancet,2022

3. Mirikizumab as induction and maintenance therapy for ulcerative colitis;D'Haens;N Engl J Med,2023

4. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): Two randomised, double-blind, placebo-controlled, phase 3 studies;Sandborn;Lancet,2023

5. Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis;Sands;N Engl J Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP